Attending the 28th Annual Meeting and Scientific Symposium?

2017 ◽  
Vol 26 (8) ◽  
pp. 868-868
Keyword(s):  
Annual Meeting ◽  
Scientific Symposium ◽  
28Th Annual Meeting

European Immunogenicity Platform 11th Open Scientific Symposium on immunogenicity of biopharmaceuticals

Bioanalysis ◽  
2020 ◽  
Vol 12 (15) ◽  
pp. 1043-1048
Author(s):  
Sophie Tourdot ◽  
Carolina B Quaglia ◽  
Paul Chamberlain ◽  
Anne S De Groot ◽  
Nikki Dellas ◽  
...  
Keyword(s):  
Patient Safety ◽  
Annual Meeting ◽  
Treatment Efficacy ◽  
Clinical Relevance ◽  
Therapeutic Protein ◽  
Medicinal Products ◽  
Scientific Symposium ◽  
Advanced Therapy Medicinal Products ◽  
Advanced Therapy ◽  
Immunogenicity Assessment

Given the expanding number of complex therapeutic protein drugs and advanced therapy medicinal products that are being developed, improving our ability to assess the potential immunogenicity of biologics is critical to ensuring treatment efficacy and patient safety. In this context, the European Immunogenicity Platform annual meeting provides opportunities for experts from industry and academia, regulators and clinicians to convene and discuss immunogenicity assessment methods and tools. This report summarizes the key messages on immunogenicity testing, prediction, clinical relevance and advanced therapy medicinal products discussed at the 11th Open Scientific European Immunogenicity Platform Symposium on Immunogenicity of Biopharmaceuticals, Lisbon, Portugal, 17–19 February 2020.

Sign in / Sign up

Export Citation Format

Share Document